Jagsonpal Pharmaceuticals standalone net profit rises 43.81% in the December 2022 quarter

Sales rise 10.41% to Rs 60.14 crore

Net profit of Jagsonpal Pharmaceuticals rose 43.81% to Rs 7.78 crore in the quarter ended December 2022 as against Rs 5.41 crore during the previous quarter ended December 2021. Sales rose 10.41% to Rs 60.14 crore in the quarter ended December 2022 as against Rs 54.47 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales60.1454.47 10 OPM %14.3510.32 -PBDT10.197.51 36 PBT9.867.14 38 NP7.785.41 44

Powered by Capital Market - Live News